The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
clinical trials
Since the Board last met
EFPIA published 'Principles for Responsible Clinical Trial Data Sharing' and their objections to the proposed EMA policy on clinical trial transparency.
The AllTrials campaign published a more detailed statement of the transparency requests. Available here.
David Preece and PAO attended a clinical trial transparency event in Brussels, conversed with Ben Goldacre and discussed EAHP-AllTrials cooperation. More information here and here. Videostream of event available here.
BEUC to support EMA in transparency court case.
Next steps
DP and PAO to attend trials transparency events on Monday 16 September and Tuesday 17 September
Response to be made to EMA consultation by 30 September. Most current EAHP draft here.
Greater cooperation with AllTrials campaign (?)
For Board consideration
Content of EAHP response to EMA consultation
Potential mobilisation of member associations
Cooperation with AllTrials campaign
Additional information
Guardian (UK) article on pharma industry lobbying ref EMA trial transparency policy here.